Gloom and Doom Meeting of docs Turns Hopeful When Patient Offers Health Reform Proposal
In Brief: Bresnick Directs Norris Cotton Cancer Center; FASEB Honors Kirschstein; Van Nevel’s 2th Year
Bosnian Research Trying To Leave, Asks For More Calls
ACS Urges Practice Of Insurance Exclusion End Under Reform
Epstein Petition Seeks Broder’s Removal As NCI Director
NIH Should Review CRADA Pricing, Wyden Write to Shalala
IOM Selects Advisors To Defense Department
“Alternative” Is Misleading Term, President’s Cancer Panel Writes To Healy
FDA Policy On Support Of Medical Education Near Final Form
Trending Stories
- An opportunity for Trump: Position U.S. cancer science to lead the world
- Former Maryland Governor Larry Hogan to receive Public Service Leadership Award from National Coalition for Cancer Survivorship
- The Directors: Tom Lynch and Skip Burris on how NIH funding cuts imperil biopharma innovation—and cost patient lives
In a time of uncertainty, “react to the knowns, not the fear” - Grilled by Congress, Kennedy defends NIH and NCI budget cuts, freezes, and RIFs
To avoid “offending” pharma, NCI doesn’t study the causes of early-onset colon cancer, HHS secretary incorrectly alleges - NIH eliminates the NCI Board of Scientific Advisors
Over its 28 year history, BSA shaped NCI-funded extramural science - Kennedy’s claims notwithstanding, NCI clinical trials are delayed, enrollments reduced
NCI’s Steven A. Rosenberg: “Almost all patients are getting delayed by about a month, but then again, we’re turning away more patients.”
